Jennifer L. Kirk received her doctorate in biostatistics from the University of Washington. Previously, she completed a two-year postbaccalaureate fellowship at the National Institute of Allergy and Infectious Diseases. In 2017, she joined the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research as a statistical reviewer of clinical and product quality/CMC statistics for vaccines, allergenics, and live biotherapeutics. She is currently a Lead Mathematical Statistican in the Device and Non-Clinical Evaluation branch, where she leads the product quality/CMC team for all of CBER’s products.